NFKB1 and cancer: In addition, drugs or inhibitors targeting inflammatory signalling pathways, such as NF-κB utilised by oncogenic viruses to establish persistent infections is expected to reduce the incidence of virus-mediated cancer, overcome tumour resistance, and enhance the synergistic effect of combination therapy [93,153].